MarketsStocksAKUMS
AK

Akums Drugs and Pharmaceuticals Ltd

NSE: AKUMSBSE: 544222Healthcare
Download Research Report7-page PDF
543.00
-1.95%
NSE · auto-updates while market open
Prev Close
₹564.15
Day High
₹557.50
Day Low
₹542.85
Mkt Cap
₹8,242 Cr
P / E
32.1
P / B
2.5
ROE
8.1%
52W High
₹597.00
52W Low
₹409.30
Key Metrics
Market Cap
₹8,242 Cr
P / E
32.14
P / B
2.49
EV / EBITDA
13.69
ROCE
14.8%
ROE
8.1%
Debt / Equity
0.02
Book Value
₹216.41
EPS
₹16.67
Div Yield
0.0%
Face Value
₹2
Promoter Holding
75.3%
Revenue · ₹ Cr
4.1k
FY25
4.4k
FY26
Net Profit · ₹ Cr
344
FY25
256
FY26
EPS · ₹ per share
₹22.6
FY25
₹16.7
FY26
P / E Ratio · price ÷ TTM EPS
1723293526120-2Apr 25Aug 25Jan 26Jun 26
P/E 32.7×Median 22.5×TTM EPS
Q1 2026 snapshot
Sales
₹1.19K Cr
Operating profit
-
OPM
-
Net profit
₹81 Cr
EPS
₹5.53
Scorecard · 7 axes
Quality
Strong
78/100
Valuation
Avg
32.1×
Growth
Strong
+39.0%
Profitability
Avg
11.4%
Performance
Bad
-1.3%
Entry Point
Weak
91%
Red Flags
Strong
0 flags
Shareholding Pattern
75.3%Promoter
Promoter75.3%
FII1.4%
DII14.3%
Public9.0%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1,010.4111,073.091,050.761,049.891,193.911,193.17
Net Profit66.312149.60664.68542.69667.67481.342
NPM %6.6%13.9%6.2%4.1%5.7%6.8%
AlertPre-trade